美国FDA药品DMF数据库
(U.S. FDA Drug Master Files)
DMF号码 DMF状态 DMF类型 提交日期 持有人 关联主题/药物名称
42307 A II 2025/08/06 PRANAMI DRUGS PRIVATE LTD MICONAZOLE NITRATE USP
42375 A II 2025/08/06 BAIZE BIOPHARMACEUTICAL (SHENZHEN) CO LTD HUMAN DERIVED UMBILICAL WHARTON'S JELLY MESENCHYMAL STEM CELL EXOSOMES
42385 A V 2025/08/06 WUXI BIOLOGICS BIOSAFETY TESTING (SUZHOU) CO LTD METHOD FOR DETECTION OF ADVENTITIOUS VIRAL CONTAMINATION IN CHO CELL BANKS
42387 A II 2025/08/06 SUZHOU RYWAY BIOTECH CO LTD IODIXANOL
42390 A II 2025/08/06 BEIYIN BIOTECHNOLOGY (ZHUHAI) CO LTD NK CELL CULTURE KIT (PLUS)
42394 A II 2025/08/06 LEE PHARMA LTD LENACAPAVIR SODIUM
42397 A II 2025/08/06 SAI SREYAS PHARMACEUTICALS PVT LTD TERT-BUTYL 6-CYANO-2-(2-(4-ETHYL-3-IODOPHENYL) PROPAN-2-YL)-1H-INDOLE-3-CARBOXYLATE (TBC) IH (CAS NUMBER- 1256584-75-4)
42416 A III 2025/08/06 PANO CAP CANADA LTD 28MM JIGGER CAP
42289 A II 2025/08/05 NEWCHEM SPA CICLESONIDE
42315 A V 2025/08/05 WUXI BIOLOGICS BIOSAFETY TESTING (SUZHOU) CO LTD METHOD FOR DETECTION OF HAMSTER /MURINE SPECIES-SPECIFIC VIRUSES SPECIFIED IN MAP AND HAP TESTS IN CELL BANK USING TARGET HIGH-THROUGHPUT SEQUENCING TECHNOLOGY
42326 A II 2025/08/05 SHANGHAI SINUOTIDES BIOPHARMACEUTICAL CO LTD NUSINERSEN SODIUM
41623 A II 2025/08/05 LINHAI TIANYU PHARMACEUTICAL CO LTD FEBUXOSTAT
42381 A II 2025/08/04 SUZHOU RYWAY BIOTECH CO LTD IOPROMIDE
42382 A II 2025/08/04 SUZHOU RYWAY BIOTECH CO LTD IOHEXOL
42386 A II 2025/08/04 SUZHOU RYWAY BIOTECH CO LTD IOPAMIDOL
42388 A II 2025/08/04 SUZHOU RYWAY BIOTECH CO LTD IOVERSOL
42389 A II 2025/08/04 SUZHOU RYWAY BIOTECH CO LTD SOFOSBUVIR
42293 A II 2025/08/02 APITORIA PHARMA PRIVATE LTD AUROPAP 90F (ACETAMINOPHEN DIRECTLY COMPRESSIBLE GRANULES)
42383 A III 2025/08/02 RENUKA PRECISION PLASTICS PVT LTD PLASTIC BOTTLES, CAPS AND CLOSURES FOR THE PHARMACEUTICAL APPLICATIONS
42384 A II 2025/08/02 SUNPURE EXTRACTS PVT LTD PTEROCARPUS MARSUPIUM EXTRACT 90%

数据库说明:

当前数据更新日期:2025年10月13日(该库为每季度更新),更多信息请点击此处查询美国FDA药品数据库
©2006-2025 DrugFuture->U.S. FDA Drug Master Files